Methods : 15 cases with primary thymic carcinoma confirmed by pathology after operation were studied retrospectively .

方法：对15例手术治疗并经病理证实的原发性 胸腺 癌 患者的临床资料进行回顾性分析，讨论该病的 诊断 及 治疗。

Synaptophysin chromogranin A and neuron-specific enolase were all positive in the 10 cases of small cell carcinoma of lung and 1 case of thymic small cell carcinoma ( which was also CD5 negative ) .

10例肺和1例 胸腺小细胞 癌突触素、嗜铬粒素A（CgA）、神经元特异性烯醇化酶（NSE）均阳性，CD5阴性；

Analysis of treatment and prognosis of 73 thymic carcinoma patients

73例 胸腺 癌的治疗与预后分析

Chest CT is an effective method for diagnosis of thymic carcinoma .

CT检查是重要的诊断方法。

Conclusion : Primary thymic carcinoma is a kind of badly maligant neoplasms with unsatisfactory prognosis .

结论：原发性 胸腺 癌是一种高度恶性肿瘤，术前确诊率较低，应早期采用外科手术治疗，预后不良。

Objective : To study the clinical characters and surgical treatment of primary thymic carcinoma .

目的：分析原发性 胸腺 癌临床特征和外科治疗。

Results There were 19 cases of thymoma 6 cases of thymolipoma 1 case of thymic carcinoma .

结果：胸腺瘤19例，胸腺脂肪瘤6例， 胸腺 鳞癌1例。

Surgical Treatment of Primary Thymic Carcinoma

原发性 胸腺 癌 15 例外科治疗分析

Clinicopathological features of thymic carcinoma and type B3 thymoma

胸腺 癌与B3型胸腺瘤的临床病理研究

2.1t is important for patients with thymoma to look for an effective therapeutic targets for targeted therapy . Further study on thymic carcinoma of c-kit mutation is an important research direction in the future .

进一步的研究 胸腺 癌 中c-kit突变，寻找有效的治疗靶点，进行有针对性的治疗，是未来重要的研究方向。

Clinicopathological features and prognosis of thymic carcinoma

胸腺 癌 患者临床病理特点和预后

【 Conclusion 】 The combined radiotherapy with thymic peptide can highly improve the survival rate of patients with nasopharyngeal carcinoma and lower its distant metastasis rate .

【结论】放疗联合 胸腺肽治疗能够明显提高 鼻咽癌患者的生存率，降低远处转移率。

Analysis on Effects of Combined Radiotherapy with Thymic Peptide in Treating Moderate-advanced Nasopharyngeal Carcinoma

放射联合 胸腺肽治疗中晚期 鼻咽癌疗效分析

The 5 year survival rate of patients with MT of predominantly cortical cortical and well differentiated thymic carcinoma ( MDTC ) subtypes was 75.3 % 44.7 % and 43.3 % respectively .

皮质为主型、皮质型、分化好的 胸腺 癌、鳞癌及淋巴上皮样癌5年生存率分别为75.3%、44.7%、43.3%、27.5%和60.0%；

The long-term outcome and prognostic analysis of 51 thymic carcinoma patients

51 例 胸腺 癌治疗结果及影响预后因素分析